Jorgensen Nathan D.

CIK 0001842523

Chief Financial Officer

Filings

Latest Feb 26, 2026

Issuers covered

Showing

18 of 18

Page 1

Track record

2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	2	50%	-1.9%	-1.9%	+5.6%	-9.3%
90 days	2	50%	+7.9%	+7.9%	+17.1%	-1.3%
180 days	1	100%	+17.9%	+17.9%	+17.9%	+17.9%
365 days	-	-	-	-	-	-

Companies where Jorgensen Nathan D. has filed

Ticker	Issuer	Filings	Last filed
VOR	Vor Biopharma Inc.	12	May 7, 2024
VYGR	Voyager Therapeutics, Inc.	6	Feb 26, 2026

18 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 26, 2026	VYGRVoyager Therapeutics, Inc.	SSale	4,668	$3.77	$17,598
Feb 10, 2026	VYGRVoyager Therapeutics, Inc.	AGrant	32,250	$0.00	$0
Oct 7, 2025	VYGRVoyager Therapeutics, Inc.	SSale	7,666	$4.78	$36,643
Feb 24, 2025	VYGRVoyager Therapeutics, Inc.	AGrant	51,500	$0.00	$0
Oct 2, 2024	VYGRVoyager Therapeutics, Inc.	AGrant	80,000	$0.00	$0
Jul 9, 2024	VYGRVoyager Therapeutics, Inc.	Holdings only	-	-	-
May 7, 2024	VORVor Biopharma Inc.	FTax	834	$1.75	$1,460
May 3, 2024	VORVor Biopharma Inc.	FTax	917	$1.77	$1,623
Mar 5, 2024	VORVor Biopharma Inc.	FTax	6,310	$2.27	$14,324
Feb 8, 2024	VORVor Biopharma Inc.	FTax	985	$2.32	$2,285
Jan 31, 2024	VORVor Biopharma Inc.	AGrant	50,000	$0.00	$0
Nov 8, 2023	VORVor Biopharma Inc.	FTax	834	$1.82	$1,518
Sep 6, 2023	VORVor Biopharma Inc.	FTax	6,310	$2.67	$16,848
Aug 9, 2023	VORVor Biopharma Inc.	FTax	834	$2.67	$2,227
May 10, 2023	VORVor Biopharma Inc.	FTax	834	$4.14	$3,453
Mar 2, 2023	VORVor Biopharma Inc.	FTax	6,310	$5.51	$34,768
Feb 8, 2023	VORVor Biopharma Inc.	AGrant	45,500	$0.00	$0
Feb 3, 2022	VORVor Biopharma Inc.	Holdings only	-	-	-

Showing 1-18 of 18

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.